StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New Press Release - StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Oct 20, 2023 3:35pm

82 Views

Post# 35693664

RE:RE:New Press Release - StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings

Exactly who do you think is actually getting this message? Maybe it was the person who just bought shares at 3 and one half cents? If you think this latest NR is going to be of any use then shake your head.